.
Why is Vendetta Pharmaceuticals Inc. stock higher today?
On Tuesday, the U.S. Food and Drug Administration (FDA) approved Vanda Pharmaceuticals Inc's (NASDAQ: VNDA) Fanapt (ipiperidone) tablets for the acute treatment of manic or mixed seizures associated with bipolar I disorder in adults, an atypical antipsychotic that has been used for the acute treatment of patients with schizophrenia since it was approved by the FDA in 2009. Fanapt is an atypical antipsychotic drug that has been used in the acute treatment of schizophrenia since it was approved by the U.S. Food and Drug Administration in 2009. Bipolar disorder is a chronic psychiatric condition that affects approximately 2.81 TP3T of U.S. adults, of which 831 TP3T are classified as severe bipolar disorder. Bipolar Disorder
English 
Chinese